Evidence map›Paper›PMID 31268609›Full record

ArticleThe EMBO journal2019

PP4-dependent HDAC3 dephosphorylation discriminates between axonal regeneration and regenerative failure.

Arnau Hervera, Luming Zhou, Ilaria Palmisano, Eilidh McLachlan, Guiping Kong, Thomas H Hutson, Matt C Danzi, Vance P Lemmon, John L Bixby, Andreu Matamoros-Angles and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. The Role of Methylation Modification in Neural Injury and Repair.International journal of molecular sciences · 2025
    Review
  7. Three-dimensional chromatin mapping of sensory neurons reveals that promoter-enhancer looping is required for axonal regeneration.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Regulation of axonal regeneration after mammalian spinal cord injury.Nature reviews. Molecular cell biology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 4 countries.

Arnau HerveraDepartment of Medicine, Division of Brain Sciences, Molecular Neuroregeneration, Imperial College London, London, UK.
Luming ZhouDepartment of Medicine, Division of Brain Sciences, Molecular Neuroregeneration, Imperial College London, London, UK.
Ilaria PalmisanoDepartment of Medicine, Division of Brain Sciences, Molecular Neuroregeneration, Imperial College London, London, UK.
Eilidh McLachlanDepartment of Medicine, Division of Brain Sciences, Molecular Neuroregeneration, Imperial College London, London, UK.
Guiping KongDepartment of Medicine, Division of Brain Sciences, Molecular Neuroregeneration, Imperial College London, London, UK.
Thomas H HutsonDepartment of Medicine, Division of Brain Sciences, Molecular Neuroregeneration, Imperial College London, London, UK.
Matt C DanziThe Miami Project to Cure Paralysis, Department of Neurological Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.
Vance P LemmonThe Miami Project to Cure Paralysis, Department of Neurological Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.ORCID 0000-0003-3550-7576
John L BixbyThe Miami Project to Cure Paralysis, Department of Neurological Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.
Andreu Matamoros-AnglesMolecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Parc Científic de Barcelona, Barcelona, Spain.
Kirsi ForsbergLaboratory for NeuroRegeneration and Repair, Center for Neurology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
Francesco De VirgiliisDepartment of Medicine, Division of Brain Sciences, Molecular Neuroregeneration, Imperial College London, London, UK.
Dina P MatheosCenter for the Neurobiology of Learning & Memory, Department of Neurobiology & Behavior, University of California, Irvine, CA, USA.
Janine KwapisCenter for the Neurobiology of Learning & Memory, Department of Neurobiology & Behavior, University of California, Irvine, CA, USA.
Marcelo A WoodCenter for the Neurobiology of Learning & Memory, Department of Neurobiology & Behavior, University of California, Irvine, CA, USA.
Radhika PuttaguntaLaboratory for NeuroRegeneration and Repair, Center for Neurology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
José Antonio Del RíoMolecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Parc Científic de Barcelona, Barcelona, Spain.
Simone Di GiovanniDepartment of Medicine, Division of Brain Sciences, Molecular Neuroregeneration, Imperial College London, London, UK.ORCID 0000-0003-3154-5399
Hertie Institute for Clinical Brain Research · DEBiomedical Research Networking Center on Neurodegenerative Diseases · ESImperial College London · GBUniversity of California, Irvine · USUniversity of Miami · USHeidelberg University · DE

Funding

Henry Smith CharityImperial Biomedical Research Centre (SDG)Medical Research Council MR/R005311/1Medical Research Council MR/T003111/1National Institute for Health Research (NIHR)Rosetrees Trustthe Spanish Ministry of Economy, Industry and Competitiveness BFU2015-67777-Rthe Spanish Ministry of Economy, Industry and Competitiveness IJCI-2016-30783Wings for Life (Wings for Life United Kingdom)
6 · The paper itself

Abstract

The molecular mechanisms discriminating between regenerative failure and success remain elusive. While a regeneration-competent peripheral nerve injury mounts a regenerative gene expression response in bipolar dorsal root ganglia (DRG) sensory neurons, a regeneration-incompetent central spinal cord injury does not. This dichotomic response offers a unique opportunity to investigate the fundamental biological mechanisms underpinning regenerative ability. Following a pharmacological screen with small-molecule inhibitors targeting key epigenetic enzymes in DRG neurons, we identified HDAC3 signalling as a novel candidate brake to axonal regenerative growth. In vivo, we determined that only a regenerative peripheral but not a central spinal injury induces an increase in calcium, which activates protein phosphatase 4 that in turn dephosphorylates HDAC3, thus impairing its activity and enhancing histone acetylation. Bioinformatics analysis of ex vivo H3K9ac ChIPseq and RNAseq from DRG followed by promoter acetylation and protein expression studies implicated HDAC3 in the regulation of multiple regenerative pathways. Finally, genetic or pharmacological HDAC3 inhibition overcame regenerative failure of sensory axons following spinal cord injury. Together, these data indicate that PP4-dependent HDAC3 dephosphorylation discriminates between axonal regeneration and regenerative failure.

Indexed as

AnimalsAxonsCells, CulturedDisease Models, AnimalEpigenesis, GeneticFemaleGanglia, SpinalHistone Deacetylase 3Histone DeacetylasesMaleMiceNerve RegenerationPeripheral Nerve InjuriesPhosphoprotein PhosphatasesPhosphorylationSignal TransductionHistone Deacetylase 3Histone DeacetylasesPhosphoprotein Phosphatasesprotein phosphatase 4Small Molecule LibrariescalciumHDAC3nerve regenerationspinal cord injurytranscription

Identifiers

PMID31268609
PMCPMC6600644
OpenAlexW2897555818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.